* To evaluate strategic options with respect to FUSE
colonoscope, and expects to provide further clarity at/around
time of deal closing
The post BRIEF-Boston Scientific to acquire EndoChoice for $8.00/share appeared first on NASDAQ.
Forex – financial instrument.Forex news
* To evaluate strategic options with respect to FUSE
colonoscope, and expects to provide further clarity at/around
time of deal closing
The post BRIEF-Boston Scientific to acquire EndoChoice for $8.00/share appeared first on NASDAQ.